nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of the Na+/H+-exchanger is NIH 3T3 fibroblasts expressing the Ha-ras oncogene requires stimulated calcium influx and is associated with rearrangement of the actin cytoskeleton
|
Ritter, M. |
|
1995 |
31 |
S3 |
p. S13- 1 p. |
artikel |
2 |
Active specific immunotherapy with Newcastle Disease Virus modified autologous tumor cells
|
Schirrmacher, V. |
|
1995 |
31 |
S3 |
p. S17- 1 p. |
artikel |
3 |
Adenovirus-mediated gene transfer of the HSV-thymidine kinase gene for the treatment of primary CNS malignancies
|
Eck, S.L. |
|
1995 |
31 |
S3 |
p. S20- 1 p. |
artikel |
4 |
Adjuvant high dose epirubicin and cyclophosphamide with G-CSF support in patients with locally advanced breast cancer
|
Konecny, G. |
|
1995 |
31 |
S3 |
p. S36- 1 p. |
artikel |
5 |
A heat inducible HSP72 associated immunogenic determinant act as a tumor specific recognition structure for NK cells
|
Botzler, C. |
|
1995 |
31 |
S3 |
p. S36- 1 p. |
artikel |
6 |
Amifostine — protection from hematotoxicity and nephrotoxicity induced by chemotherapy
|
Oster, W. |
|
1995 |
31 |
S3 |
p. S37- 1 p. |
artikel |
7 |
An autocrine factor of an ovarian carcinoma cell line induces C-MYC transcripts, DNA-synthesis and apoptosis
|
Krupitza, G. |
|
1995 |
31 |
S3 |
p. S24- 1 p. |
artikel |
8 |
Antibodies from phage libraries clinical imaging trial of a filamentous bacteriophage-derived single chain Fv anti-CEA expressed in E. coli
|
Begent, RHJ |
|
1995 |
31 |
S3 |
p. S14- 1 p. |
artikel |
9 |
Antigens recognized on human tumors by cytolytic T lymphocytes
|
Coulie, Pierre |
|
1995 |
31 |
S3 |
p. S19- 1 p. |
artikel |
10 |
Apoptosis and the treatment of chronic lymphoid malignancies: the B-chronic lymphocytic leukemia (B-CLL) model
|
Caligaris-Cappio, F. |
|
1995 |
31 |
S3 |
p. S9- 1 p. |
artikel |
11 |
A proliferation assay to determine specific T-cell immunity using HLA I-binding peptides
|
Scheibenbogen, C |
|
1995 |
31 |
S3 |
p. S23- 1 p. |
artikel |
12 |
A randomized trial of IFNα and IL-2 ± cisplatinum in advanced melanoma — a preliminary analysis
|
Keilholz, U |
|
1995 |
31 |
S3 |
p. S25- 1 p. |
artikel |
13 |
A stress inducible HSP72 cell surface expression is observed selectively on human tumor cells
|
Wiesner, M. |
|
1995 |
31 |
S3 |
p. S36- 1 p. |
artikel |
14 |
Bacterial endotoxin sensitizes human endothelial cells against radiation-induced programmed cell death through the action of transmembrane TNF-α
|
Einer, G. |
|
1995 |
31 |
S3 |
p. S24- 1 p. |
artikel |
15 |
Bryostatin 1 regulates multi drug resistance by a PKC-independent mechanism
|
Utz, I. |
|
1995 |
31 |
S3 |
p. S13- 1 p. |
artikel |
16 |
CD4 positive, HLA-DR restricted T cell response to human IFN-γ treated sarcoma cells. Functions, specificity and cytokine profiles
|
Heike, M. |
|
1995 |
31 |
S3 |
p. S29- 1 p. |
artikel |
17 |
Cellular immunotherapy of acute leukemia with natural killer cells in an animal model
|
|
|
1995 |
31 |
S3 |
p. S35- 1 p. |
artikel |
18 |
Clinical application of haemopoietic growth factors — state of the art
|
Crowther, D. |
|
1995 |
31 |
S3 |
p. S6- 1 p. |
artikel |
19 |
Clinical applications of erythropoietin(EPO) in pediatrics
|
Morschchakova, Elena F. |
|
1995 |
31 |
S3 |
p. S33- 1 p. |
artikel |
20 |
Clinical aspects of cytokine control of B-lymphopoiesis
|
Hiddemann, W. |
|
1995 |
31 |
S3 |
p. S9- 1 p. |
artikel |
21 |
Clinical experience with rH GM-CSF(leucomax) in advanced neoplasias
|
Iosub, A. |
|
1995 |
31 |
S3 |
p. S38- 1 p. |
artikel |
22 |
Clinical results of two different dose regimens with high-dose interferon-alpha and interleukin-2 in advanced renal cell cancer and malignant melanoma
|
Fenchel, K. |
|
1995 |
31 |
S3 |
p. S29- 1 p. |
artikel |
23 |
Clinical trials of anti-angiogenic agents
|
Hawkins, MJ |
|
1995 |
31 |
S3 |
p. S14- 1 p. |
artikel |
24 |
Cytokine gene therapy with gene transfected cells: Long term expression in vivo and therapeutic potential
|
Rosenthal, F.M. |
|
1995 |
31 |
S3 |
p. S19- 1 p. |
artikel |
25 |
Cytokine gene transfer: First clinical trials
|
Gansbacher, B. |
|
1995 |
31 |
S3 |
p. S19- 1 p. |
artikel |
26 |
Detection of tumor cells in the bone marrow of breast cancer patients by cytokeratin 19 — reverse-transcriptase — polymerase chain reaction (RT-PCR)
|
Nestle-Krämling, C. |
|
1995 |
31 |
S3 |
p. S35- 1 p. |
artikel |
27 |
Development and initial clinical studies of TA-HPV in cervical cancer
|
Borysiewicz, L.K. |
|
1995 |
31 |
S3 |
p. S17- 1 p. |
artikel |
28 |
Development of a biological response modifiers system based upon stimulation of blood with ozone ex vivo and reinfusion
|
Bocci, V. |
|
1995 |
31 |
S3 |
p. S32- 1 p. |
artikel |
29 |
Development of a MDR-1 gene specific ribozyme: A molecular approach to the reversal of drug resistance of cancer cells
|
Kiehntopt, M. |
|
1995 |
31 |
S3 |
p. S17- 1 p. |
artikel |
30 |
Differential effects of an ifosfamide treatment on intracellular glutathione (GSH) levels of lymphocyte subsets correlates with immunological functions
|
Multhoff, G. |
|
1995 |
31 |
S3 |
p. S37- 1 p. |
artikel |
31 |
Differentiation and proliferation in haemopoietic cells
|
Whetton, A.D. |
|
1995 |
31 |
S3 |
p. S5- 1 p. |
artikel |
32 |
Effective treatment of radiotherapy-induced thrombocytopenia with interleukin-3 (IL-3)
|
Färber, L. |
|
1995 |
31 |
S3 |
p. S30- 1 p. |
artikel |
33 |
Effect of alpha-2 interferon (a2-INF) FND myelosan(Busulfan) on haematopoiesis and bone marrou environment in patients with chronic myelocytic leukemia(CML)
|
Abdulkadirov, K. |
|
1995 |
31 |
S3 |
p. S29- 1 p. |
artikel |
34 |
Effects of bleomycin on leukotriene production in mast cells in vitro and in patients in vivo
|
Geuenich, S. |
|
1995 |
31 |
S3 |
p. S33- 1 p. |
artikel |
35 |
Effects produced by a new bacterial substance on the processes of cell proliferation
|
Rugal, V. |
|
1995 |
31 |
S3 |
p. S37- 1 p. |
artikel |
36 |
Efficient costimulatory signal for T cell proliferation induced by human lymphoma cells transduced with B7-1 and B7-2 molecules by recombinant adeno-associated virus (AAV) vectors
|
Mangold, Elisabeth |
|
1995 |
31 |
S3 |
p. S26- 1 p. |
artikel |
37 |
Erythropoietin for chronic anemia of cancer: Treatment results and prediction of responsiveness
|
Ludwig, H. |
|
1995 |
31 |
S3 |
p. S6- 1 p. |
artikel |
38 |
Expression and cloning of LST-1: A novel gene in the human TNF region
|
Rollinger-Holzinger, I. |
|
1995 |
31 |
S3 |
p. S37- 1 p. |
artikel |
39 |
Frequency and function of IL-2 receptor α, β and γ cains on blast cells from acute myelocytic leukemia
|
Weidmann, E. |
|
1995 |
31 |
S3 |
p. S23- 1 p. |
artikel |
40 |
Further characterisation of two different resistant human leukemia cell lines with respect to apoptosis induction
|
Stötzer, O. |
|
1995 |
31 |
S3 |
p. S34- 1 p. |
artikel |
41 |
G-CSF and IL-6 serum-levels in patients with myelodysplastic syndromes and aplastic anemia
|
Nerl, C. |
|
1995 |
31 |
S3 |
p. S32- 1 p. |
artikel |
42 |
Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer
|
Philip, Ramila |
|
1995 |
31 |
S3 |
p. S35- 1 p. |
artikel |
43 |
Generation of cytotoxic T lymphocytes (CTL) in HLA haplo- and identical individuals to investigate graft versus leukemia effects
|
Froer, M. |
|
1995 |
31 |
S3 |
p. S31- 1 p. |
artikel |
44 |
Gene transfer-mediated expression of costimulatory melocules to enhance the immunogenicity of human tumor cells
|
Moebius, U. |
|
1995 |
31 |
S3 |
p. S25- 1 p. |
artikel |
45 |
GM-CSF/IL3 fusion protein (pixy 321) and other growth factors in acute myeloid leukemia blasts
|
Tafuri, A. |
|
1995 |
31 |
S3 |
p. S5- 1 p. |
artikel |
46 |
Growth factor receptors as targets for drug development
|
Ullrich, A. |
|
1995 |
31 |
S3 |
p. S13- 1 p. |
artikel |
47 |
Growth factor regulation of normal hematopoiesis
|
Hogge, D.E. |
|
1995 |
31 |
S3 |
p. S5- 1 p. |
artikel |
48 |
Human allogeneic NK-cells activated by IL-2 and IL-12 efficientyl lyse fresh acute leukemia blasts
|
Glass, B. |
|
1995 |
31 |
S3 |
p. S23- 1 p. |
artikel |
49 |
Identification and characterization of murine stem cells with preferential short-term or long-term bone marrow repopulating ability
|
Fibbe, W.E. |
|
1995 |
31 |
S3 |
p. S5- 1 p. |
artikel |
50 |
IL-4 induced upregulation of BCL-2 in CLL patients in vivo and in vitro
|
Karakas, T. |
|
1995 |
31 |
S3 |
p. S32- 1 p. |
artikel |
51 |
Immune reconstitution of severe combined immune deficient (SCID) mice: A potential model for testing immune gene therapy for acute myeloid leukaemia
|
Hollingsworth, S.J. |
|
1995 |
31 |
S3 |
p. S26- 1 p. |
artikel |
52 |
Immunization with anti-idiotype vaccine SCV 106 prolongs survival time of cancer patients with metastatic colorectal cancer: A randomized double blind clinical trial
|
Samonigg, H. |
|
1995 |
31 |
S3 |
p. S25- 1 p. |
artikel |
53 |
Immuno-gene therapy of rat glioma with TGF-β2 antisense and IL-2 gene modified tumor cells
|
Sobol, RE |
|
1995 |
31 |
S3 |
p. S20- 1 p. |
artikel |
54 |
Immunomagnetic removal of tumor cells using monoclonal antibodies against B-cell epitopes or tumor associated breast cancer antigens
|
Brockmeyer, C. |
|
1995 |
31 |
S3 |
p. S32- 1 p. |
artikel |
55 |
Immunotherapeutic approaches directed against minimal residual cancer
|
Pantel, Klaus |
|
1995 |
31 |
S3 |
p. S38- 1 p. |
artikel |
56 |
Immunotherapy in acute leukemias — A new therapeutic approach?
|
Bergmann, L. |
|
1995 |
31 |
S3 |
p. S9- 1 p. |
artikel |
57 |
Induction of apoptosis and anergy in resting human T-lymphocytes after CD3-triggering and its modulation by CD28 and cytokines
|
Müller, Y. |
|
1995 |
31 |
S3 |
p. S34- 1 p. |
artikel |
58 |
Interactions of TGFα and TGFβ in the regulation of epithelial cell growth
|
Leake, Robin |
|
1995 |
31 |
S3 |
p. S13- 1 p. |
artikel |
59 |
Interferon-alpha and vinblastine versus medroxy-progesteronacetat in the treatment of metastatic renal cell carcinoma
|
Kriegmair, M. |
|
1995 |
31 |
S3 |
p. S35- 1 p. |
artikel |
60 |
Interleukin-2 transfected melanoma cells for tumor vaccination. — From animal models to clinical trials —
|
Maass, G. |
|
1995 |
31 |
S3 |
p. S18- 1 p. |
artikel |
61 |
In vivo gene therapy of metastatic melanoma using the HSVtk gene by co-activation of anti-tumour immunity
|
Castleden, Simon |
|
1995 |
31 |
S3 |
p. S20- 1 p. |
artikel |
62 |
Lymphokine induced differentiation of human nonlyphocytic leukemia cell lines
|
Stöckbauer, P. |
|
1995 |
31 |
S3 |
p. S31- 1 p. |
artikel |
63 |
Mechanisms of erythropoietin action
|
Pavlov, Anatol D. |
|
1995 |
31 |
S3 |
p. S33- 1 p. |
artikel |
64 |
Molecular cytokine regulation by interferon-α (IFN-α) in bone marrow stromal cells: A possible paracrine mode of action in chronic myeloid leukemia (CML)
|
Derigs, H.G. |
|
1995 |
31 |
S3 |
p. S23- 1 p. |
artikel |
65 |
Monoclonal antibody (MAB) treatment of resected Dukes C colorectal carcinoma (CRC): A prospective randomized trial
|
Riethmüller, G. |
|
1995 |
31 |
S3 |
p. S14- 1 p. |
artikel |
66 |
Plasmid vaccination for B-cell lymphoma
|
Hawkins, Robert E |
|
1995 |
31 |
S3 |
p. S18- 1 p. |
artikel |
67 |
Post-marketing surveillance study on the treatment of solid tumors with filgrastim
|
Maschek, U. |
|
1995 |
31 |
S3 |
p. S30- 1 p. |
artikel |
68 |
Preclinical and clinical results in breast cancer overexpressing HER-2
|
Slamon, D. |
|
1995 |
31 |
S3 |
p. S14- 1 p. |
artikel |
69 |
Prostaglandins and leukotrienes modulate proliferation of normal and transformed blood cells
|
Haberl, C. |
|
1995 |
31 |
S3 |
p. S33- 1 p. |
artikel |
70 |
Receptor binding, activation of cAMP dependent protein kinase (PKA) signal transduction pathways and induction of interleukin-8 (IL-8) mRNA by A (1→3)-β-D-glucan biological response modifier in the human monocyte-like cell line U937
|
Müller, A. |
|
1995 |
31 |
S3 |
p. S24- 1 p. |
artikel |
71 |
Recombinant human stem cell factor protects CD34 positive human myeloid leukemia cells from the chemotherapy-induced apoptosis
|
Hassan, H.T. |
|
1995 |
31 |
S3 |
p. S34- 1 p. |
artikel |
72 |
Recombinant single chain immunotoxins specific for the EGF receptor and ErbB-2
|
Schmidt, Mathias |
|
1995 |
31 |
S3 |
p. S34- 1 p. |
artikel |
73 |
Retrovirus mediated gene transfer for gene therapy
|
Günzburg, Walter H. |
|
1995 |
31 |
S3 |
p. S19- 1 p. |
artikel |
74 |
Retrovirus-mediated gene transfer of B7.1 into primary acute myeloid leukaemia blasts
|
Buggins, A.S. |
|
1995 |
31 |
S3 |
p. S26- 1 p. |
artikel |
75 |
Sequential interferon alfa 2B with chemotherapy in metastatic ovarian cancer. Phase II. Study
|
Adorjan, G. |
|
1995 |
31 |
S3 |
p. S29- 1 p. |
artikel |
76 |
Strategies for the development of a tumor vaccine for non-Hodgkin's lymphoma
|
Hallek, M. |
|
1995 |
31 |
S3 |
p. S18- 1 p. |
artikel |
77 |
Synergistic cytotoxic and cytostatic interactions between interferon-alpha and chemotherapeutic drugs in human myeloid leukaemia cells
|
Hassan, H.T. |
|
1995 |
31 |
S3 |
p. S30- 1 p. |
artikel |
78 |
Systemic and cellular release of IL-10 in human BMT
|
Holler, E |
|
1995 |
31 |
S3 |
p. S24- 1 p. |
artikel |
79 |
Targeted eradication of ErbB-2 over-expressing tumor cells employing expression of an intracellular antibody directed against the ErbB-2 oncoprotein
|
Deshane, J. |
|
1995 |
31 |
S3 |
p. S17- 1 p. |
artikel |
80 |
The combination of interferon-alpha, all-trans retinoic acid and topical mechlorethamine in the treatment of cutaneous T-cell lymphomas
|
Lin, Xie-Yi |
|
1995 |
31 |
S3 |
p. S30- 1 p. |
artikel |
81 |
The effect of TNF alfa on the cytotoxic activity of natural killer cells in vitro
|
Konjević, G. |
|
1995 |
31 |
S3 |
p. S31- 1 p. |
artikel |
82 |
The use of genetically modified tumor cells as a vaccine in patients with cancer: The definition of intermediate end-points
|
Rankin, E.M. |
|
1995 |
31 |
S3 |
p. S18- 1 p. |
artikel |
83 |
Thrombopoietin (TPO): Basic biology, clinical promise
|
Kaushansky, K. |
|
1995 |
31 |
S3 |
p. S6- 1 p. |
artikel |
84 |
TIL culture and expansion from 42 human tumors. Reinfusion for immunoadoptive therapy in 15 patients: Preliminary data
|
Ridolfi, R. |
|
1995 |
31 |
S3 |
p. S31- 1 p. |
artikel |
85 |
Transfer of the metallothionein gene to CD34+ cells using an original friend virus derived construct confers resistance to cis-platinium derivatives and to alkylating agents
|
Cohen-Haguenauer, Odile |
|
1995 |
31 |
S3 |
p. S20- 1 p. |
artikel |
86 |
Vaccination of rhesus monkeys with an anti-idiotype antibody mumicking Lewis Y: Enhancement of the anti-tumor immune response by repeated administrations of recombinant human GM-CSF.
|
Loibner, H. |
|
1995 |
31 |
S3 |
p. S36- 1 p. |
artikel |
87 |
4-year survival data of patients with advanced renal cell carcinoma treated with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon-alpha2b
|
Pomer, S. |
|
1995 |
31 |
S3 |
p. S25- 1 p. |
artikel |